Lamisil At

Terbinafine, the active ingredient in Lamisil At, is an allylamine antifungal presented as a topical formulation for skin use. It treats dermatophyte infections of the skin and nails, such as athlete’s foot, ringworm, and jock itch, in adult and pediatric patients.

GNH USA supplies Lamisil At as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU market standards and is manufactured under GMP conditions.

Lamisil At is an allylamine antifungal used to treat infections caused by dermatophyte fungi.

- Tinea corporis: clears the skin rash and eliminates the causative fungus. - Tinea pedis: reduces itching and resolves athlete’s foot lesions. - Tinea cruris: alleviates inflammation in the groin area and eradicates fungal growth. - Tinea barbae: treats fungal infection of the beard region, restoring normal skin. - Dermatophytosis: provides broad‑spectrum control of skin‑surface fungal infections.

Common Side Effects: - Itching at the application site: mild to moderate discomfort. - Burning sensation: transient warmth during use. - Redness: localized erythema. - Scaling or flaking: dry skin patches. - Irritation: occasional stinging. - Dryness: reduced skin moisture.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or difficulty breathing. - Severe skin rash: widespread redness or blistering. - Stevens‑Johnson syndrome: rare but life‑threatening mucocutaneous reaction. - Contact dermatitis: persistent inflammation at the site. - Urticaria: sudden hives. - Facial swelling: indicates systemic hypersensitivity.

Before using Lamisil At, consider the following precautions. - Pregnancy: consult a healthcare professional before application. - Breastfeeding: discuss potential risks with a physician. - Age restrictions: not recommended for children under 2 years unless directed by a clinician. - Pre‑existing skin conditions: avoid use on eczematous or inflamed skin. - Occlusion: do not cover the treated area with airtight dressings. - Store at room temperature: keep in the original container, protect from moisture and light.

Terbinafine topical may interact with other skin‑applied agents.

Major Interactions (Avoid): - Systemic terbinafine: concurrent use can increase systemic exposure. - Other topical antifungals: may cause additive irritation.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antifungal efficacy. - Alcohol‑based cleansers: can increase skin dryness. - Phototoxic agents: monitor for increased skin sensitivity to light.